Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

Fluxo de Caixa das Atividades de Investimento de Verve Therapeutics, Inc..

Dados anuais

2020

2021

2022

2023

2024

TTM

‪‪−240,00 M‬‬

‪‪−160,00 M‬‬

‪‪−80,00 M‬‬

‪0,00‬

‪‪80,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪74,88 M‬‬

‪0,00‬

‪0,00‬%

2024

‪‪74,88 M‬‬

+‪‪47,19 M‬‬

+‪170,41‬%

2023

‪‪27,69 M‬‬

+‪‪183,65 M‬‬

—

2022

‪‪−155,96 M‬‬

+‪‪83,14 M‬‬

+‪34,77‬%

2021

‪‪−239,10 M‬‬

‪‪−187,97 M‬‬

‪−367,66‬%

2020

‪‪−51,13 M‬‬

‪‪−38,37 M‬‬

‪−300,74‬%

Dados trimestrais

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−60,00 M‬‬

‪‪−30,00 M‬‬

‪0,00‬

‪‪30,00 M‬‬

‪‪60,00 M‬‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪29,55 M‬‬

‪‪−27,27 M‬‬

‪−47,99‬%

Q3 '24

‪‪56,81 M‬‬

+‪‪26,66 M‬‬

+‪88,43‬%

Q2 '24

‪‪30,15 M‬‬

+‪‪71,78 M‬‬

—

Q1 '24

‪‪−41,63 M‬‬

‪‪−32,74 M‬‬

‪−368,14‬%

Q4 '23

‪‪−8,89 M‬‬

+‪‪2,94 M‬‬

+‪24,85‬%

Q3 '23

‪‪−11,83 M‬‬

‪‪−44,86 M‬‬

‪−135,83‬%

Q2 '23

‪‪33,02 M‬‬

+‪‪17,63 M‬‬

+‪114,56‬%

Q1 '23

‪‪15,39 M‬‬

+‪‪183,71 M‬‬

—

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20